Overview
The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.
Eligibility
Inclusion Criteria:
- Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy.
Exclusion Criteria:
- Pregnant/lactating women.
- There are other factors that the researchers think are not suitable for inclusion